Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T Therapy.

EJHaem · 2025 · PMC11920814 · PMID 40110072

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.115not close (p > 0.1)

showed a trendno p-value reported

Patients who were CD19‐positive for qPCR but negative for IHC (IHC − qPCR + ) showed a trend toward worse PFS than IHC+ ones, although the difference did not reach statistical significance (33 vs. 46%, p = 0.115).

also in 53,322 other papers

a statistical trendno p-value reported

There were no differences in response rates based on CD19 expression, although there was a statistical trend toward worse DOR in CD19‐negative patients.

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.